Details for Patent: 8,940,786
✉ Email this page to a colleague
Which drugs does patent 8,940,786 protect, and when does it expire?
Patent 8,940,786 protects DOCETAXEL and is included in one NDA.
This patent has twenty-six patent family members in twenty-one countries.
Summary for Patent: 8,940,786
Title: | Non-aqueous taxane nanodispersion formulations and methods of using the same |
Abstract: | Non-aqueous, ethanol-free taxane nanodispersion formulations are provided. Nanodispersion formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the nanodispersion formulations, as well as kits that include the nanodispersion formulations. Non-aqueous, ethanol-free docetaxel nanodispersion formulations are provided. Nanodispersion formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the nanodispersion formulations, as well as kits that include the nanodispersion formulations. |
Inventor(s): | Nabeta; Kiichiro (Tokyo, JP) |
Assignee: | Teikoku Pharma USA, Inc. (San Jose, CA) |
Application Number: | 14/041,675 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; Device; |
Patent landscape, scope, and claims: | More… ↓ |
Drugs Protected by US Patent 8,940,786
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-001 | Dec 22, 2015 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION | ⤷ Subscribe | ||
Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-002 | Dec 22, 2015 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION | ⤷ Subscribe | ||
Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 205934-003 | Dec 22, 2015 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,940,786
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 092759 | ⤷ Subscribe | |||
Australia | 2013327563 | ⤷ Subscribe | |||
Brazil | 112015006692 | ⤷ Subscribe | |||
Canada | 2885930 | ⤷ Subscribe | |||
China | 104822262 | ⤷ Subscribe | |||
China | 108464969 | ⤷ Subscribe | |||
European Patent Office | 2903435 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |